This inventor holds 1 USPTO granted patent. Top assignees: Seoul National University, The Industry & Academic Cooperation in Chungnam National University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Jang Jay Sohn: Innovator in Arrhythmia Treatment Technology
Introduction
Jang Jay Sohn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the treatment of arrhythmia. His innovative approach combines electrical stimulation with biosignal monitoring to enhance patient care.
Latest Patents
Jang Jay Sohn holds a patent for an "Arrhythmia treatment device and method for treating arrhythmia of user by using same." This device includes a first electrode that outputs a stimulus to electrically stimulate the user's nerves based on input treatment conditions. Additionally, a second electrode measures the user's biosignals for a predetermined time interval after the stimulus is applied. A controller then checks the treatment results based on the measured biosignals and adjusts the output of the first electrode accordingly.
Career Highlights
Throughout his career, Jang Jay Sohn has worked with prestigious institutions, including Seoul National University and the Industry & Academic Cooperation in Chungnam National University. His work has focused on advancing medical technologies that improve patient outcomes.
Collaborations
Jang has collaborated with notable colleagues, including Yunseo Ku and Hee Chan Kim. Their combined expertise has contributed to the development of innovative solutions in the medical field.
Conclusion
Jang Jay Sohn's contributions to arrhythmia treatment technology exemplify the impact of innovation in healthcare. His patented device represents a significant advancement in the way arrhythmia is treated, showcasing the importance of research and collaboration in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile